What is the share price of Max Healthcare Institute Ltd (MAXHEALTH) today?
The share price of MAXHEALTH as on 23rd May 2025 is ₹1177.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Max Healthcare Institute Ltd (MAXHEALTH) share?
The past returns of Max Healthcare Institute Ltd (MAXHEALTH) share are- Past 1 week: -3.02%
- Past 1 month: 0.81%
- Past 3 months: 16.52%
- Past 6 months: 21.13%
- Past 1 year: 42.98%
- Past 3 years: 221.44%
- Past 5 years: 953.33%
What are the peers or stocks similar to Max Healthcare Institute Ltd (MAXHEALTH)?
The peers or stocks similar to Max Healthcare Institute Ltd (MAXHEALTH) include:What is the dividend yield % of Max Healthcare Institute Ltd (MAXHEALTH) share?
The current dividend yield of Max Healthcare Institute Ltd (MAXHEALTH) is 0.13.What is the market cap of Max Healthcare Institute Ltd (MAXHEALTH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Max Healthcare Institute Ltd (MAXHEALTH) is ₹111621.90 Cr as of 23rd May 2025.What is the 52 week high and low of Max Healthcare Institute Ltd (MAXHEALTH) share?
The 52-week high of Max Healthcare Institute Ltd (MAXHEALTH) is ₹1227.95 and the 52-week low is ₹743.10.What is the PE and PB ratio of Max Healthcare Institute Ltd (MAXHEALTH) stock?
The P/E (price-to-earnings) ratio of Max Healthcare Institute Ltd (MAXHEALTH) is 103.75. The P/B (price-to-book) ratio is 13.28.Which sector does Max Healthcare Institute Ltd (MAXHEALTH) belong to?
Max Healthcare Institute Ltd (MAXHEALTH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Max Healthcare Institute Ltd (MAXHEALTH) shares?
You can directly buy Max Healthcare Institute Ltd (MAXHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Max Healthcare Institute Ltd
MAXHEALTH Share Price
1,177.102.52% (+28.90)
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
MAXHEALTH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 103.75 | 13.28 | 0.13% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.78 | 6.46 | 0.86% |
MAXHEALTH Analyst Ratings & Forecast
Detailed Forecast 75%
Analysts have suggested that investors can buy this stock
from 20 analysts
Price Upside
Earnings Growth
Rev. Growth
MAXHEALTH Company Profile
Max Healthcare is provider of home health care services including Patient Care, Healthcare Services, and Hospitals.
MAXHEALTH Similar Stocks (Peers)
Compare with peersAPOLLOHOSP
PE Ratio
111.28
1Y Return
18.33%
Buy Reco %
86.21
FORTIS
PE Ratio
70.58
1Y Return
53.33%
Buy Reco %
100.00
PE Ratio
44.33
1Y Return
37.39%
Buy Reco %
66.67
MEDANTA
PE Ratio
66.09
1Y Return
1.46%
Buy Reco %
71.43
ASTERDM
PE Ratio
5.28
1Y Return
52.63%
Buy Reco %
100.00
MAXHEALTH Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
MAXHEALTH Stock Summary · February 2025
The company demonstrated robust financial performance in Q3 FY25, achieving over 30% year-on-year growth in revenue and EBITDA, bolstered by strategic acquisitions and new hospital launches. Despite facing challenges such as political unrest and regulatory hurdles, strong operational efficiencies and a commitment to community engagement have enhanced its market position, particularly in the Delhi NCR and Lucknow regions. The focus on optimizing the payor mix and expanding capacity is expected to drive further growth, with anticipated revisions in CGHS rates likely to improve institutional revenue. Additionally, effective cost management strategies and a proactive approach to financial planning are set to sustain profitability while supporting ongoing expansion initiatives.
Key Points on Maxhealth Stock
MAXHEALTH Stock Growth Drivers
8Strong Financial Performance
The company reported significant financial achievements, including over 30% year-on-year growth in revenue, EBITDA, and
EBITDA Breakeven and Operational Efficiency
The company achieved EBITDA breakeven in December 2024, just six months after launching a new
MAXHEALTH Stock Challenges
4Flat Revenue and Declining Profitability
The company reported flat revenue from existing units in Q3, which is typically a weak
Competitive Landscape and Market Challenges
The competitive environment in regions like Lucknow remains challenging, with major players like Apollo and
MAXHEALTH Forecasts
MAXHEALTH Forecast
Price
Revenue
Earnings
MAXHEALTH Share Price Forecast
2025
Current
₹1,177.10
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹1,177.10
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
MAXHEALTH Company Revenue Forecast
2025
Current
₹7.18
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹7.18
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
MAXHEALTH Stock EPS (Earnings Per Share) Forecast
2025
Current
₹11.07
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹11.07
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
MAXHEALTH
Income
Balance Sheet
Cash Flow
Annual Normal View
MAXHEALTH Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,667.82 | 1,794.47 | 1,748.07 | 1,956.85 | 2,619.41 | 4,290.79 | 4,970.61 | 5,882.27 | 7,184.10 | 7,184.20 | ||||||||||
Raw Materials | 423.00 | 431.05 | 362.20 | 409.14 | 580.51 | 930.46 | 936.88 | 1,119.04 | 5,253.29 | 5,253.39 | ||||||||||
| Power & Fuel Cost | 40.90 | 41.36 | 46.06 | 38.93 | 51.37 | 62.67 | 69.04 | 77.54 | ||||||||||||
| Employee Cost | 353.47 | 422.91 | 440.55 | 449.24 | 588.78 | 768.95 | 810.04 | 937.12 | ||||||||||||
| Selling & Administrative Expenses | 593.95 | 647.99 | 630.23 | 191.43 | 208.86 | 510.39 | 631.33 | 741.49 | ||||||||||||
| Operating & Other expenses | 56.61 | 72.57 | 56.80 | 506.63 | 904.99 | 957.43 | 1,143.55 | 1,336.89 | ||||||||||||
EBITDA | 199.89 | 178.59 | 212.23 | 361.48 | 284.90 | 1,060.89 | 1,379.77 | 1,670.19 | 1,930.81 | 1,930.81 | ||||||||||
| Depreciation/Amortization | 95.51 | 94.42 | 102.64 | 119.74 | 174.09 | 221.12 | 232.19 | 244.98 | 359.42 | 359.42 | ||||||||||
| PBIT | 104.38 | 84.17 | 109.59 | 241.74 | 110.81 | 839.77 | 1,147.58 | 1,425.21 | 1,571.39 | 1,571.39 | ||||||||||
| Interest & Other Items | 99.68 | 99.37 | 101.27 | 152.66 | 179.46 | 100.87 | 83.86 | 59.89 | 165.02 | 165.02 | ||||||||||
| PBT | 4.70 | -15.20 | 8.32 | 89.08 | -68.65 | 738.90 | 1,063.72 | 1,365.32 | 1,406.37 | 1,406.37 | ||||||||||
| Taxes & Other Items | -11.09 | 9.95 | 11.33 | -6.26 | 68.90 | 133.85 | -39.79 | 307.68 | 330.49 | 330.49 | ||||||||||
| Net Income | 15.79 | -25.15 | -3.01 | 95.34 | -137.55 | 605.05 | 1,103.51 | 1,057.64 | 1,075.88 | 1,075.88 | ||||||||||
| EPS | 0.29 | -0.47 | -0.06 | 1.77 | -1.83 | 6.25 | 11.37 | 10.89 | 11.07 | 11.07 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.50 | 1.50 | 1.50 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.14 | 0.14 | 0.14 |
MAXHEALTH Company Updates
FY 2020
Annual report
PDFMAXHEALTH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Max Healthcare Institute Ltd | 103.75 | 13.28 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 111.28 | 13.66 | 0.23% |
| Fortis Healthcare Ltd | 70.58 | 6.39 | 0.14% |
| Narayana Hrudayalaya Ltd | 44.33 | 12.13 | 0.23% |
MAXHEALTH Stock Price Comparison
Compare MAXHEALTH with any stock or ETFCompare MAXHEALTH with any stock or ETF
MAXHEALTH
MAXHEALTH Shareholdings
MAXHEALTH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MAXHEALTH Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 2.19%
MAXHEALTH Shareholding Pattern
MAXHEALTH Shareholding History
Foreign Institutions
Mutual Funds Invested in MAXHEALTH
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has increased by 1.65%
Top 5 Mutual Funds holding Max Healthcare Institute Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9808% | Percentage of the fund’s portfolio invested in the stock 3.94% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/28 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7772% | Percentage of the fund’s portfolio invested in the stock 1.17% | Change in the portfolio weight of the stock over the last 3 months 0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 22/118 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7567% | Percentage of the fund’s portfolio invested in the stock 1.70% | Change in the portfolio weight of the stock over the last 3 months 0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 47/69 (-31) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing MAXHEALTH stock
Looks like this stock is not in any smallcase yet.
MAXHEALTH Events
MAXHEALTH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MAXHEALTH Upcoming Dividends
No upcoming dividends are available
MAXHEALTH Past Dividends
Cash Dividend
Ex DateEx DateAug 23, 2024
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Aug 23, 2024
Cash Dividend
Ex DateEx DateSep 8, 2023
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 8, 2023
MAXHEALTH Stock News & Opinions
Articles & Videos
Earnings
Max Healthcare Institute consolidated net profit rises 26.82% in the March 2025 quarter
Net profit of Max Healthcare Institute rose 26.82% to Rs 319.00 crore in the quarter ended March 2025 as against Rs 251.54 crore during the previous quarter ended March 2024. Sales rose 34.21% to Rs 1909.74 crore in the quarter ended March 2025 as against Rs 1422.90 crore during the previous quarter ended March 2024. For the full year,net profit rose 1.72% to Rs 1075.88 crore in the year ended March 2025 as against Rs 1057.64 crore during the previous year ended March 2024. Sales rose 30.01% to Rs 7028.46 crore in the year ended March 2025 as against Rs 5406.02 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1909.741422.90 34 7028.465406.02 30 OPM %26.7926.81 -26.3027.60 - PBDT503.33406.05 24 1839.421610.30 14 PBT402.50335.73 20 1480.001365.32 8 NP319.00251.54 27 1075.881057.64 2 Powered by Capital Market - Live
2 days agoCapital Market - Live
Corporate
Board of Max Healthcare Institute recommends final dividend
Max Healthcare Institute announced that the Board of Directors of the Company at its meeting held on 20 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.Powered by Capital Market - Live
2 days agoCapital Market - Live
Corporate
Board of Max Healthcare Institute approves expansion of bed capacity of MSSH Nagpur
The Board of Max Healthcare Institute at its meeting held on 20 May 2025 has approved the expansion of bed capacity of Max Super Speciality Hospital, Nagpur (MSSH Nagpur) by adding ~100 beds to the existing bed capacity of 186 beds by way of construction of two additional floors on the existing building. MSSH Nagpur is run and operated by Alexis Multi-Speciality Hospital, a wholly-owned subsidiary of the Company. Powered by Capital Market - Live
3 days agoCapital Market - Live
Corporate
Max Healthcare Institute to conduct board meeting
Max Healthcare Institute will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Max Healthcare Institute receives affirmation in credit ratings from CARE
Max Healthcare Institute has received affirmation in credit ratings for bank facilities of Rs 951.01 crore at CARE AA+; Stable / CARE A1+. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
NCLT sanctions scheme of amalgamation between ALPS Hospital & Max Hospitals and Allied Services
Max Healthcare Institute announced that the Hon'ble National Company Law Tribunal, Mumbai Bench has sanctioned the scheme of amalgamation between ALPS Hospital & Max Hospitals and Allied Services (wholly owned subsidiaries of the company) vide order dated 25 February 2025 with appointed date of 01 April 2024. Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
Max Healthcare gains on broker upgrade
The broker revised its rating on the healthcare chain from Neutral to Buy and increased the target price to Rs 1,200. The brokerage's optimistic outlook is based on Max Healthcare's robust earnings growth potential, underpinned by strong fundamentals. According to the report, the company's ambitious plan to double its bed capacity within the next three years is a key driver for future growth. The company's asset-light model distinguishes it as a leader in the healthcare sector, allowing for efficient expansion and profitability, it added. Max Healthcare Institute is one of India's largest healthcare organizations. It operates 22 healthcare facilities (5,000+ beds) with a significant presence in North India. On a consolidated basis, net profit of Max Healthcare Institute declined 17.47% to Rs 238.80 crore while net sales rose 39.95% to Rs 1868.31 crore in Q3 December 2024 over Q3 December 2023. The company reported an exceptional loss of Rs 73.63 crore in Q3 December 2024 stemming from charges paid to Yamuna Expressway Industrial Development Authority (YEIDA) for seeking permission for change in shareholding of Jaypee Healthcare. Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Max Healthcare Institute board approves amendment to lease agreement for proposed hospital in Zirakpur, Punjab
The Board of Max Healthcare Institute at its meeting held on 30 January 2025 has approved an amendment to the existing agreement to lease dated 01 August 2024 with Silicon Constructions to increase the bed capacity of the proposed hospital at Zirakpur, Punjab from the earlier 250 beds to a 400+ bedded facility. Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Board of Max Healthcare Institute approves lease agreement for 500-bed hospital in Thane
The Board of Max Healthcare Institute at its meeting held on 30 January 2025 has approved to enter into an agreement to lease with VR Konkan for setting up ~500 bedded hospital at Thane, Maharashtra on a built-to-suit basis.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Max Healthcare Institute consolidated net profit declines 17.47% in the December 2024 quarter
Net profit of Max Healthcare Institute declined 17.47% to Rs 238.80 crore in the quarter ended December 2024 as against Rs 289.34 crore during the previous quarter ended December 2023. Sales rose 39.95% to Rs 1868.31 crore in the quarter ended December 2024 as against Rs 1334.97 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1868.311334.97 40 OPM %26.7228.90 - PBDT480.04420.64 14 PBT382.50359.68 6 NP238.80289.34 -17 Powered by Capital Market - Live
3 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 27.47%, vs industry avg of 10.01%
Over the last 5 years, market share increased from 4.76% to 9.25%